Drugs / PTM-001
last change Jun 2024 re-read 3 minutes ago

PTM-001

Developed for
hidradenitis suppurativa
Investigated by
Phoenicis Therapeutics

Trials 1

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05020730 May 2022 → Dec 2023 hidradenitis suppurativa Phoenicis Therapeutics Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PTM-001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05020730 ↗